Unitised with Profits – Gamaliel's Advice

1992 ◽  
Vol 44 ◽  
pp. 243-294
Author(s):  
J. E. O'Neill ◽  
H. W. Froggatt

AbstractThe paper deals with the development of unitised with-profits business in the United Kingdom. The authors trace the recent history of these products and comment on the main reasons for their development. They also deal with corporate issues, including implications for policyholders and shareholders of different fund structures and different types of life office. Pricing and product development issues are also covered. Reserving issues including the range of valuation methods, statutory requirements and policyholders' reasonable expectations are explored. Finally the paper considers the actuary's contribution to the management of unitised with-profits policyholders' expectations.

1993 ◽  
Vol 120 (3) ◽  
pp. 415-469 ◽  
Author(s):  
J. E. O'Neill ◽  
H. W. Froggatt

The paper deals with the development of unitised with-profits business in the United Kingdom. The authors trace the recent history of these products and comment on the main reasons for their development They also deal with corporate issues, including implications for policyholders and shareholders of different fund structures and different types of life office. Pricing and product development issues are also covered. Reserving issues including the range of valuation methods, statutory requirements and policyholders' reasonable expectations are explored. Finally the paper considers the actuary's contribution to the management of unitised with-profits policyholders' expectations.


1992 ◽  
Vol 108 (1) ◽  
pp. 59-65 ◽  
Author(s):  
M. L. M. Hall ◽  
B. Rowe

Salmonella arizonaeare rarely isolated in the UK. Since 1966 there have been sixty-six isolates from humans of whom 35% gave a recent history of foreign travel. Terrapins and snakes are potential sources of infection.


2017 ◽  
Vol 181 (13) ◽  
pp. 346-346 ◽  
Author(s):  
John Graham-Brown ◽  
Paul Gilmore ◽  
Vito Colella ◽  
Lyndsay Moss ◽  
Chris Dixon ◽  
...  

In July 2016 we described the first known case of canine ocular thelaziosis in the UK in a dog recently imported from Romania. Here we confirm our initial diagnosis using PCR followed by sequence analysis, and we report a further two clinical cases in dogs with recent history of travel to Italy and France. In view of the presence in the UK of the vector forThelazia callipaeda, namelyPhorticaspp, we discuss the significance of these three cases in the context of the UK government’s pet travel scheme, disease control and both animal and public health in the UK.


2019 ◽  
Vol 2019 (11) ◽  
pp. 135-139
Author(s):  
Maria Zhukova ◽  
Elena Maystrovich ◽  
Elena Muratova ◽  
Aleksey Fedyakin

Author(s):  
Ros Scott

This chapter explores the history of volunteers in the founding and development of United Kingdom (UK) hospice services. It considers the changing role and influences of volunteering on services at different stages of development. Evidence suggests that voluntary sector hospice and palliative care services are dependent on volunteers for the range and quality of services delivered. Within such services, volunteer trustees carry significant responsibility for the strategic direction of the organiszation. Others are engaged in diverse roles ranging from the direct support of patient and families to public education and fundraising. The scope of these different roles is explored before considering the range of management models and approaches to training. This chapter also considers the direct and indirect impact on volunteering of changing palliative care, societal, political, and legislative contexts. It concludes by exploring how and why the sector is changing in the UK and considering the growing autonomy of volunteers within the sector.


Religions ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 97
Author(s):  
Georgina M. Robinson

In an age where concern for the environment is paramount, individuals are continuously looking for ways to reduce their carbon footprint—does this now extend to in one’s own death? How can one reduce the environmental impact of their own death? This paper considers various methods of disposing the human body after death, with a particular focus on the environmental impact that the different disposal techniques have. The practices of ‘traditional’ burial, cremation, ‘natural’ burial, and ‘resomation’ will be discussed, with focus on the prospective introduction of the funerary innovation of the alkaline hydrolysis of human corpses, trademarked as ‘Resomation’, in the United Kingdom. The paper situates this process within the history of innovative corpse disposal in the UK in order to consider how this innovation may function within the UK funeral industry in the future, with reference made to possible religious perspectives on the process.


Blood ◽  
2011 ◽  
Vol 117 (23) ◽  
pp. 6367-6370 ◽  
Author(s):  
Charles R.M. Hay ◽  
Ben Palmer ◽  
Elizabeth Chalmers ◽  
Ri Liesner ◽  
Rhona Maclean ◽  
...  

Abstract The age-adjusted incidence of new factor VIII inhibitors was analyzed in all United Kingdom patients with severe hemophilia A between 1990 and 2009. Three hundred fifteen new inhibitors were reported to the National Hemophilia Database in 2528 patients with severe hemophilia who were followed up for a median (interquartile range) of 12 (4-19) years. One hundred sixty (51%) of these arose in patients ≥ 5 years of age after a median (interquartile range) of 6 (4-11) years' follow-up. The incidence of new inhibitors was 64.29 per 1000 treatment-years in patients < 5 years of age and 5.31 per 1000 treatment-years at age 10-49 years, rising significantly (P = .01) to 10.49 per 1000 treatment-years in patients more than 60 years of age. Factor VIII inhibitors arise in patients with hemophilia A throughout life with a bimodal risk, being greatest in early childhood and in old age. HIV was associated with significantly fewer new inhibitors. The inhibitor incidence rate ratio in HIV-seropositive patients was 0.32 times that observed in HIV-seronegative patients (P < .001). Further study is required to explore the natural history of later-onset factor VIII inhibitors and to investigate other potential risk factors for inhibitor development in previously treated patients.


Sign in / Sign up

Export Citation Format

Share Document